A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
Recruiting · NCT06063681 · Registry updated 2025-06-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors | Disease Attributes, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm | Recruiting | Phase 1 | 2025-06-08 | NCT06063681 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stingray Therapeutics | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Monash Health | Clayton | Australia | 74 |
| Peninsula & South Eastern Haematology & Oncology Group | Frankston | Australia | 2 |
| Scientia Clinical Research Ltd | Randwick | Australia | 11 |